Lee Financial CO Intra Cellular Therapies, Inc. Transaction History

Lee Financial CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $1,752 - $2,279	40 Added 18.18%	260 $14,000
Q3 2022 Nov 01, 2022	BUY	$42.7 - $59.99 $9,394 - $13,197	220 New	220 $10,000
Q4 2019 Feb 14, 2020	SELL	$7.26 - $38.49 $3,630 - $19,245	-500 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$7.47 - $14.03 $3,735 - $7,015	500 New	500 $4,000
Q4 2018 Feb 11, 2019	SELL	$10.36 - $20.96 $2,072 - $4,192	-200 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$17.77 - $22.9 $2,665 - $3,435	-150 Reduced 42.86%	200 $4,000
Q2 2018 Aug 14, 2018	BUY	$17.33 - $23.4 $4,627 - $6,247	267 Added 321.69%	350 $6,000
Q1 2018 May 09, 2018	BUY	$15.16 - $25.49 $1,258 - $2,115	83 New	83 $2,000

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.87B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.